Reno-30® is a radiopaque contrast agent indicated for retrograde or ascending pyelography. Retrograde pyelography does not include systemic administration of contrast media, so the risk of adverse reactions is extremely rare.

Reno-60® is radiopaque contrast agent with a wide range of indications. Reno-60 should be at body temperature when injected and may need to be warmed before use. Following intravascular injection, iodinated contrast materials are transported through the bloodstream to the kidneys and excreted by glomerular filtration.

RenoCal®-76 (diatrizoate meglumine and diatrizoate sodium) was used as a contrast agent. Bracco Diagnostics, Inc. stated that the production of Renocal-76 has been discontinued due to reduced demand.

Renografin®-60 (diatrizoate meglumine and diatrizoate sodium) was used as a radiopaque contrast agent. Bracco Diagnostics, Inc. states that the production of Renografin-60 has been discontinued due to reduced demand.

Sinografin® (diatrizoate meglumine and iodipamide meglumine) is a contrast agent indicated for use in hysterosalpingography. Intrauterine used contrast agents have few known pharmacological effects. Most of the medium within the uterine cavity is discharged immediately after finishing of the procedure and the contrast medium retained is completely absorbed.